Check Your Claims Before Reviewers Do

Verify your claims against versioned evidence records with exact reported results and sources.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review claims

Explore by Goal

Quick Explanation Copied

The supplied evidence contains no author metadata, so the scientific strength of 'Ana Lonic' cannot be assessed.

Long Explanation

Missing Author Evidence

The supplied claim-level records describe ten papers spanning PKCδ phosphorylation, endosomal trafficking (VipD/Rab5, COMMD3, TWIK2), phosphoproteomics, and plant profilin tyrosine phosphorylation, but none contain author names, affiliations, h-index, or attribution data. No record connects any paper to an author named 'Ana Lonic', and the query provides no publications, methods descriptions, or citation history for this individual.

To perform a rigorous Author Review, what is missing: (1) a verified publication list with authorship position; (2) citation metrics and reproducibility track record; (3) declared conflicts of interest; (4) the specific roles in the supplied studies (e.g., the PKCδ and TiO₂ phosphopeptide enrichment papers, which score 8–9 on extraction quality but name no authors). Confidence in any author-level verdict here is near zero; fabricating one would violate evidence-based review standards.

Feedback:

Updated: October 26, 2026

BGPT Author Review

Scientific Quality

30%

No scientific output attributable to 'Ana Lonic' exists in the supplied evidence records; no publication list, methods contributions, or citation metrics are available. Any score reflects absence of evidence rather than demonstrated weak science, and could change substantially with verified authorship data.

Communication Quality

20%

No writing samples, abstracts, or communications attributable to this author are supplied; communication quality is unverifiable from the records provided.

Author Novelty

30%

Novelty cannot be attributed without verified authorship; the associated papers show high novelty (e.g., novel TiO₂ on-target phosphopeptide enrichment, Commander-independent COMMD3 function), but author identity is unconfirmed.

Scientific Rigor

30%

Rigor cannot be assessed for an unverified author; the underlying papers report solid methods (mutagenesis, SILAC phosphoproteomics, CRISPR screens) but attribution to this individual is not established.

Top Data Sources Export MCP

1. This study reveals that proteolytic cleavage of PKCδ to the δKD fragment yields a kinase whose catalytic activity is gated by Thr507 and C-tail priming phosphorylations, with Src-mediated Tyr334 phosphorylation and G-loop Ser359 phosphorylation modulating δKD activity, and demonstrates how cellular context (e.g., doxorubicin-treated cardiomyocytes) affects δKD regulation and function. [2017]

9QualityResults Limitations Context Blindspots Methods Sample Data

↗ Paper Review ↗ Full Paper

2. This study demonstrates a novel titanium dioxide-based on-target enrichment method for the characterization of phosphorylations in the Adenovirus pIIIa protein, revealing three new phosphorylation sites and the ability to detect multi-phosphorylated peptides. [2013]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

3. This study shows that Phaseolus vulgaris expresses at most two proline genes (one in root nodules) and that in vivo phosphorylation on tyrosine residues generates multiple proline isoforms, providing evidence for plant tyrosine kinases and linking proline phosphorylation to actin cytoskeleton regulation and signal transduction. [1999]

9QualityResults Limitations Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

4. A comprehensive review of how reversible phosphorylation regulates auxin biosynthesis, transport and signaling in plants, highlighting key kinases and phosphatases (e.g., PID/WAGs, D6PK, PAX, TMK/MAPK axis, PP2A, BRX, MAB4/MELs) and the emerging phosphorylation code that modulates PIN polarity and transport activity, while outlining major open questions and future directions. [2021]

8QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

5. This study reveals that the Legionella pneumophila effector protein VipD targets and interferes with endosomal trafficking in macrophages by binding to activated Rab5 and Rab22, thereby blocking their interactions with downstream effectors and inhibiting lysosomal degradation. [2012]

8QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

Key Insight

Author-level review requires attributable provenance; paper-level quality scores in the records (7–9) cannot be transferred to an individual without explicit authorship linkage, a common but often overlooked failure mode in bibliometric synthesis.

Keep Exploring

Which specific methodological contributions (e.g., TiO₂ on-target enrichment vs. mutagenesis design) best discriminate author expertise levels in phosphorylation biology?

How does the reliability of bibliometric author scoring change when provenance metadata (ORCID, CRediT) is verified versus inferred from co-occurrence?

Hypothesis Graveyard

Assuming 'Ana Lonic' authored the supplied phosphorylation papers because they co-occur in a query: no record lists any author names, so this inference is unsupported and rejected.

Assuming paper quality scores (7–9) proxy author skill: scores describe papers, not individuals, and conflating them is a known attribution fallacy.

Potential Experiments

Cross-reference ORCID/PubMed author disambiguation against the 19 supplied DOIs (e.g., 10.1128/MCB.00324-17, 10.1016/j.chroma.2013.08.096) to verify or refute authorship before scoring.

Extract author contribution statements (CRediT taxonomy) from the full texts of the highest-scoring records to quantify this author's specific methodological role.

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My scoring defaults penalize absent data rather than distinguishing 'unverifiable' from 'weak', and my extraction pipeline may under-report author metadata present in original full texts.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

My BGPT

Trending